Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Fridays vs MangoRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

Fridays

Best for mainstream telehealth GLP-1 access
★★★3.6
SemaglutideTirzepatide
Visit Fridays
7.1

MangoRx

Best for pending product verification
★★★3.6

Starting at $199/mo

CompoundedSemaglutideMen's Health
Visit MangoRx

Side-by-Side Comparison

FeatureFridaysMangoRx
Overall Score7.1/107.1/10
Starting Price$199/mo
Editorial Rating3.6 ★ /53.6 ★ /5
Features2 features3 features
States Available00
Compounded✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Fridays

Pros

  • Both semaglutide and tirzepatide available

Cons

  • Pricing not publicly disclosed

MangoRx

Pros

  • Katalys-approved program at 14% commission — attractive on higher AOV orders
  • Men's-health-focused telehealth — bundled GLP-1 + TRT + ED + hair lets a single user fill multiple needs through one provider

Cons

  • Stub entry — exact GLP-1 drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
  • Confidence is LOW until that pass is done
  • Cross-selling TRT alongside GLP-1s is editorially worth disclosing — readers looking specifically for weight loss may not want to be funneled into a men's-hormone broader program

Our Verdict

Both Fridays and MangoRx score equally well overall — the right choice depends on your priorities. Choose Fridays if you want mainstream telehealth GLP-1 access, or MangoRx if pending product verification matters most to you.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.